GRCE

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Grace Therapeutics, Inc.

NASDAQ | GRCE

3.16

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 25, 2025)

$48.41M

Market Cap

-

P/E Ratio

-0.53

EPS

$4.97

52 Week High

$1.75

52 Week Low

HEALTHCARE

Sector

GRCE Chart

Recent Chart
Price Action

GRCE Technicals

Tags:

GRCE Earnings

Yearly Income Statement (As of Mar 31, 2025)

Field Value (USD)
Gross Profit -$7K
Total Revenue $0
Cost Of Revenue $7K
Costof Goods And Services Sold $7K
Operating Income -$17M
Selling General And Administrative $7.2M
Research And Development $9.5M
Operating Expenses $17M
Investment Income Net -
Net Interest Income $711K
Interest Income $711K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $7K
Income Before Tax -$13M
Income Tax Expense -$3.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$9.6M
Comprehensive Income Net Of Tax -
Ebit -$17M
Ebitda -$17M
Net Income -$9.6M

Revenue & Profitability

Earnings Performance

GRCE Financials

yearly Balance Sheet (As of Mar 31, 2025)

Field Value (USD)
Total Assets $72M
Total Current Assets $23M
Cash And Cash Equivalents At Carrying Value $22M
Cash And Short Term Investments $22M
Inventory -
Current Net Receivables $126K
Total Non Current Assets $49M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $41M
Intangible Assets Excluding Goodwill $41M
Goodwill $8.1M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $453K
Other Non Current Assets -
Total Liabilities $5.4M
Total Current Liabilities $1.9M
Current Accounts Payable $601K
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $3.5M
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $1.3M
Other Non Current Liabilities -
Total Shareholder Equity $67M
Treasury Stock -
Retained Earnings -$221M
Common Stock $1K
Common Stock Shares Outstanding $12M

yearly Cash Flow (As of Mar 31, 2025)

Field Value (USD)
Operating Cashflow -$15M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $7K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $14M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$9.6M

yearly Income Statement (As of Mar 31, 2025)

Field Value (USD)
Gross Profit -$7K
Total Revenue $0
Cost Of Revenue $7K
Costof Goods And Services Sold $7K
Operating Income -$17M
Selling General And Administrative $7.2M
Research And Development $9.5M
Operating Expenses $17M
Investment Income Net -
Net Interest Income $711K
Interest Income $711K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $7K
Income Before Tax -$13M
Income Tax Expense -$3.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$9.6M
Comprehensive Income Net Of Tax -
Ebit -$17M
Ebitda -$17M
Net Income -$9.6M

GRCE News

GRCE Profile

Grace Therapeutics, Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Grace Therapeutics, Inc., based in Princeton, New Jersey, is an innovative pharmaceutical company committed to pioneering therapies for rare and orphan diseases. Leveraging cutting-edge research techniques and extensive clinical knowledge, Grace seeks to fulfill significant unmet medical needs both in Canada and globally. With a strong portfolio of specialized products in its pipeline, the company aims to improve patient outcomes and establish itself as a key player in the rare disease therapeutics market, reinforcing its position as a leader in this critical area of healthcare.

LPTX
+368.57%
$2.05
RUBI
+30.25%
$0.19
VHAI
0.00%
$0.00
ONDS
+29.47%
$8.72
IVP
+22.52%
$0.19
CETY
+75.70%
$1.88
NVDA
-5.94%
$171.70
TWOH
-13.33%
$0.00
AXDX
-61.36%
$0.03
PFE
+0.71%
$25.22
INHD
-8.87%
$0.43
ADAP
-15.14%
$0.05
NIO
-3.65%
$5.54
CMND
-17.02%
$0.16
SOND
-23.45%
$0.12
PCG
+1.78%
$15.95
IONQ
+12.10%
$46.76
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
WULF
+11.86%
$12.63
GOOGL
+1.47%
$323.27
LNAI
+15.74%
$1.47
VSA
-26.87%
$0.13
SRM
+53.27%
$10.30
RELI
-8.05%
$0.66
VNRX
-9.63%
$0.30
HOOD
+7.14%
$114.97
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
BE
+6.18%
$95.56
BMNU
+39.92%
$7.36
FLEX
+3.00%
$56.95
APLD
+12.80%
$23.79
AUTL
+11.29%
$1.38
AEHL
+21.34%
$3.07
ASST
-6.19%
$1.06
VINE
+21.15%
$0.30
PLUG
-2.80%
$1.90
GOOG
-0.13%
$318.03
BTG
+3.95%
$4.33
AFMD
-34.94%
$0.18
CHR
+5.65%
$0.04
AMD
-9.11%
$195.44
CNC
+4.57%
$38.17
INTC
-0.46%
$35.62
SOFI
+0.72%
$27.60
OSRH
+15.14%
$0.74
KSS
+34.13%
$21.09
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
BSX
+1.19%
$98.04
DVLT
-13.84%
$2.08
BABA
-2.57%
$156.58
BYND
-1.39%
$0.85
NVVE
+9.37%
$0.26
CIFR
-1.79%
$16.41
YGMZ
-84.87%
$0.16
SAND
-6.04%
$12.12
AVGO
-1.00%
$374.16
CRCA
+3.08%
$3.68
IREN
-7.40%
$44.90
RGTI
-4.44%
$25.39
SHOT
-74.37%
$0.39
PG
-2.61%
$146.98
BITF
-3.58%
$2.69
ZAPP
-46.30%
$0.15
AAPL
+0.95%
$278.56
AMZN
+0.69%
$227.85
KDLY
+0.24%
$0.44
BMNR
-3.40%
$30.04
AAL
+4.08%
$13.63
CAN
-5.61%
$0.90
UUUU
+9.31%
$13.97
TSLA
-2.03%
$409.28
ORCL
-3.16%
$193.94
BBD
+1.00%
$3.51
KOS
-2.56%
$1.14
TEVA
+2.31%
$24.77
SBET
+5.88%
$10.08
MARA
-3.86%
$10.77
PLTR
-2.68%
$157.88
CRWV
-9.36%
$66.70
GLXY
+5.80%
$24.78
NVO
+3.22%
$46.41
AGNC
+0.29%
$10.33
IONZ
+4.71%
$4.89
FI
-0.27%
$60.67
BAC
+0.78%
$52.33
META
+2.29%
$627.10
CWVX
-10.74%
$4.65
F
+1.33%
$13.13
NWTN
-6.32%
$0.69
AIIO
-6.32%
$0.69
MP
+6.82%
$59.04
KGC
+6.47%
$25.97
VLY
+3.24%
$11.12
VALE
+0.49%
$12.15
CCL
+5.27%
$26.06
NEHC
+15.78%
$4.40
LPTX
+368.57%
$2.05
RUBI
+30.25%
$0.19
VHAI
0.00%
$0.00
ONDS
+29.47%
$8.72
IVP
+22.52%
$0.19
CETY
+75.70%
$1.88
NVDA
-5.94%
$171.70
TWOH
-13.33%
$0.00
AXDX
-61.36%
$0.03
PFE
+0.71%
$25.22
INHD
-8.87%
$0.43
ADAP
-15.14%
$0.05
NIO
-3.65%
$5.54
CMND
-17.02%
$0.16
SOND
-23.45%
$0.12
PCG
+1.78%
$15.95
IONQ
+12.10%
$46.76
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
WULF
+11.86%
$12.63
GOOGL
+1.47%
$323.27
LNAI
+15.74%
$1.47
VSA
-26.87%
$0.13
SRM
+53.27%
$10.30
RELI
-8.05%
$0.66
VNRX
-9.63%
$0.30
HOOD
+7.14%
$114.97
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
BE
+6.18%
$95.56
BMNU
+39.92%
$7.36
FLEX
+3.00%
$56.95
APLD
+12.80%
$23.79
AUTL
+11.29%
$1.38
AEHL
+21.34%
$3.07
ASST
-6.19%
$1.06
VINE
+21.15%
$0.30
PLUG
-2.80%
$1.90
GOOG
-0.13%
$318.03
BTG
+3.95%
$4.33
AFMD
-34.94%
$0.18
CHR
+5.65%
$0.04
AMD
-9.11%
$195.44
CNC
+4.57%
$38.17
INTC
-0.46%
$35.62
SOFI
+0.72%
$27.60
OSRH
+15.14%
$0.74
KSS
+34.13%
$21.09
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
BSX
+1.19%
$98.04
DVLT
-13.84%
$2.08
BABA
-2.57%
$156.58
BYND
-1.39%
$0.85
NVVE
+9.37%
$0.26
CIFR
-1.79%
$16.41
YGMZ
-84.87%
$0.16
SAND
-6.04%
$12.12
AVGO
-1.00%
$374.16
CRCA
+3.08%
$3.68
IREN
-7.40%
$44.90
RGTI
-4.44%
$25.39
SHOT
-74.37%
$0.39
PG
-2.61%
$146.98
BITF
-3.58%
$2.69
ZAPP
-46.30%
$0.15
AAPL
+0.95%
$278.56
AMZN
+0.69%
$227.85
KDLY
+0.24%
$0.44
BMNR
-3.40%
$30.04
AAL
+4.08%
$13.63
CAN
-5.61%
$0.90
UUUU
+9.31%
$13.97
TSLA
-2.03%
$409.28
ORCL
-3.16%
$193.94
BBD
+1.00%
$3.51
KOS
-2.56%
$1.14
TEVA
+2.31%
$24.77
SBET
+5.88%
$10.08
MARA
-3.86%
$10.77
PLTR
-2.68%
$157.88
CRWV
-9.36%
$66.70
GLXY
+5.80%
$24.78
NVO
+3.22%
$46.41
AGNC
+0.29%
$10.33
IONZ
+4.71%
$4.89
FI
-0.27%
$60.67
BAC
+0.78%
$52.33
META
+2.29%
$627.10
CWVX
-10.74%
$4.65
F
+1.33%
$13.13
NWTN
-6.32%
$0.69
AIIO
-6.32%
$0.69
MP
+6.82%
$59.04
KGC
+6.47%
$25.97
VLY
+3.24%
$11.12
VALE
+0.49%
$12.15
CCL
+5.27%
$26.06
NEHC
+15.78%
$4.40
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.